BACKGROUND: Vaso-occlusive crisis (VOC) the hallmark of sickle cell disease (SCD) is often treated inadequately in the emergency department (ED). We hypothesized that pain management plans individualized for each patient can improve pain management and lead to high levels of patient satisfaction. PROCEDURE: Starting in 2002, we treated all patients with SCD reporting to Children's Hospital of Pittsburgh (CHP) ED with VOC using a structured algorithm. We recorded regimens used successfully for each patient as an "individualized pain plan" and implemented it during subsequent VOC visits and adjusted it to patient response. We compared rates of hospitalization following an ED visit with VOC and readmission within 1 week after discharge for CHP with that of four comparable hospitals from Pediatric Health Information (PHIS) database. Patients and parents completed surveys of satisfaction with pain management and with care. RESULTS: Between 2002 and 2008 there was a greater decline in the rate of admission of patients presenting to the ED at CHP (78% to 52%) as compared to PHIS (71% to 68%), (P < 0.05) and readmission rates at CHP (7.3% to 3.2%) as compared to PHIS (6.5% to 5.1%) (P < 0.05). Improvement in pain score during ED management was 2.0 or more on a Wong Baker scale of 0-5 (P < 0.01). Participants on average, rated quality of pain management as very good or higher. CONCLUSION: Individualized pain management plans in the ED are effective in delivering high quality management of VOC and are associated with a high level of patient satisfaction and decreased avoidable hospitalizations.
BACKGROUND: Vaso-occlusive crisis (VOC) the hallmark of sickle cell disease (SCD) is often treated inadequately in the emergency department (ED). We hypothesized that pain management plans individualized for each patient can improve pain management and lead to high levels of patient satisfaction. PROCEDURE: Starting in 2002, we treated all patients with SCD reporting to Children's Hospital of Pittsburgh (CHP) ED with VOC using a structured algorithm. We recorded regimens used successfully for each patient as an "individualized pain plan" and implemented it during subsequent VOC visits and adjusted it to patient response. We compared rates of hospitalization following an ED visit with VOC and readmission within 1 week after discharge for CHP with that of four comparable hospitals from Pediatric Health Information (PHIS) database. Patients and parents completed surveys of satisfaction with pain management and with care. RESULTS: Between 2002 and 2008 there was a greater decline in the rate of admission of patients presenting to the ED at CHP (78% to 52%) as compared to PHIS (71% to 68%), (P < 0.05) and readmission rates at CHP (7.3% to 3.2%) as compared to PHIS (6.5% to 5.1%) (P < 0.05). Improvement in pain score during ED management was 2.0 or more on a Wong Baker scale of 0-5 (P < 0.01). Participants on average, rated quality of pain management as very good or higher. CONCLUSION: Individualized pain management plans in the ED are effective in delivering high quality management of VOC and are associated with a high level of patient satisfaction and decreased avoidable hospitalizations.
Authors: Jason Payne; Inmaculada Aban; Lee M Hilliard; Jennifer Madison; Christina Bemrich-Stolz; Thomas H Howard; Amanda Brandow; Emily Waite; Jeffrey D Lebensburger Journal: Pediatr Blood Cancer Date: 2018-08-27 Impact factor: 3.167
Authors: Paula Tanabe; Susan Silva; Hayden B Bosworth; Regina Crawford; Judith A Paice; Lynne D Richardson; Christopher N Miller; Jeffrey Glassberg Journal: Am J Hematol Date: 2017-11-10 Impact factor: 10.047
Authors: LaʼKita M J Knight; Elijah O Onsomu; Hayden B Bosworth; Regina D Crawford; Theresa DeMartino; Jeffrey Glassberg; Judith A Paice; Christopher N Miller; Lynne Richardson; Paula Tanabe Journal: Adv Emerg Nurs J Date: 2019 Jan/Mar
Authors: Jeffrey Glassberg; Jena Simon; Nilesh Patel; Jordan M Jeong; Justin J McNamee; Gary Yu Journal: Am J Emerg Med Date: 2015-07-17 Impact factor: 2.469
Authors: Ryan J Coller; Thomas S Klitzner; Carlos F Lerner; Bergen B Nelson; Lindsey R Thompson; Qianqian Zhao; Adrianna A Saenz; Siem Ia; Jessica Flores-Vazquez; Paul J Chung Journal: Pediatrics Date: 2018-07-11 Impact factor: 7.124
Authors: Seethal A Jacob; Emily L Mueller; Anneli R Cochrane; Aaron E Carroll; William E Bennett Journal: Pediatr Blood Cancer Date: 2019-11-14 Impact factor: 3.167
Authors: Emily L Mueller; Anneli R Cochrane; Courtney M Moore; Kelli B Jenkins; Nerissa S Bauer; Sarah E Wiehe Journal: J Pediatr Hematol Oncol Date: 2020-11 Impact factor: 1.170
Authors: Jena L Welch-Coltrane; Anthony A Wachnik; Meredith C B Adams; Cherie R Avants; Howard A Blumstein; Amber K Brooks; Andrew M Farland; Joshua B Johnson; Manoj Pariyadath; Erik C Summers; Robert W Hurley Journal: Pain Med Date: 2021-08-06 Impact factor: 3.750